Kiromic BioPharma Inc. Watch

from S-1/A 21 pages Warrant to Purchase Common Stock Kiromic Biopharma, Inc

from S-1/A 15 pages Pre-Funded Common Stock Purchase Warrant Kiromic Biopharma, Inc

from S-1/A 38 pages Warrant Agent Agreement

from S-1/A 16 pages Common Stock Purchase Warrant Kiromic Biopharma, Inc

from 10-K 2 pages Description of Securities

from S-8 17 pages Kiromic Biopharma, Inc. 2021 Omnibus Equity Incentive Plan

from S-1 15 pages Warrant to Purchase Common Stock

from 10-K 2 pages Description of Securities

from S-8 16 pages Kiromic, Inc. 2017 Equity Incentive Plan as Adopted on January 20, 2017

from 10-Q 17 pages The Registered Holder of This Purchase Warrant by Its Acceptance Hereof, Agrees That It Will Not Sell, Transfer or Assign This Purchase Warrant Except as Herein Provided and the Registered Holder of This Purchase Warrant Agrees That It Will Not Sell, Transfer, Assign, Pledge or Hypothecate This Purchase Warrant for a Period of One Hundred Eighty Days Following the Date of the Underwriting Agreement (Defined Below) to Anyone Other Than (I) Thinkequity, a Division of Fordham Financial Management, Inc., or an Underwriter or a Selected Dealer in Connection With the Offering, or (II) a Bona Fide Officer or Partner of Thinkequity, a Division of Fordham Financial Management, Inc., or of Any Such Underwriter or Selected Dealer. ​ This Purchase Warrant Is Not Exercisable Prior to April 13, 2021. Void After 5:00 P.M., Eastern Time, October 15, 2025. ​ Warrant to Purchase Common Stock Kiromic BioPharma Inc. Warrant Shares: . . Initial Exercise Date: April 13, 2021 This Warrant to Purchase Common Stock (The “Warrant”) Certifies That, for Value Received,

from S-1/A 16 pages Form of Representative’s Warrant Agreement

from S-1 18 pages Article 1 Exercise

from DRS/A 18 pages Article 1 Exercise